You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 23, 2024

Dimyristoyl lecithin; perflexane - Generic Drug Details


✉ Email this page to a colleague

« Back to Dashboard


What are the generic sources for dimyristoyl lecithin; perflexane and what is the scope of patent protection?

Dimyristoyl lecithin; perflexane is the generic ingredient in one branded drug marketed by Vesselon Spv Llc and is included in one NDA. Additional information is available in the individual branded drug profile pages.

Summary for dimyristoyl lecithin; perflexane
US Patents:0
Tradenames:1
Applicants:1
NDAs:1
Raw Ingredient (Bulk) Api Vendors: 72
DailyMed Link:dimyristoyl lecithin; perflexane at DailyMed

US Patents and Regulatory Information for dimyristoyl lecithin; perflexane

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Vesselon Spv Llc IMAGENT dimyristoyl lecithin; perflexane INJECTABLE;INTRAVENOUS 021191-001 May 31, 2002 DISCN No No ⤷  Subscribe ⤷  Subscribe ⤷  Subscribe
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for dimyristoyl lecithin; perflexane

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Vesselon Spv Llc IMAGENT dimyristoyl lecithin; perflexane INJECTABLE;INTRAVENOUS 021191-001 May 31, 2002 ⤷  Subscribe ⤷  Subscribe
Vesselon Spv Llc IMAGENT dimyristoyl lecithin; perflexane INJECTABLE;INTRAVENOUS 021191-001 May 31, 2002 ⤷  Subscribe ⤷  Subscribe
Vesselon Spv Llc IMAGENT dimyristoyl lecithin; perflexane INJECTABLE;INTRAVENOUS 021191-001 May 31, 2002 ⤷  Subscribe ⤷  Subscribe
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

Dimyristoyl lecithin; perflexane Market Analysis and Financial Projection Experimental

Market Dynamics and Financial Trajectory for Dimyristoyl Lecithin and Related Compounds

Introduction

Dimyristoyl lecithin, a specific type of lecithin, is a phospholipid that plays a crucial role in various industries, including pharmaceuticals, cosmetics, and food. Understanding the market dynamics and financial trajectory of dimyristoyl lecithin and related compounds like perflexane is essential for investors, manufacturers, and consumers.

Global Lecithin Market Overview

The global lecithin market is projected to experience significant growth over the next few years. By 2032, the market is expected to reach USD 2.07 billion, growing at a CAGR of 5.86% from an estimated USD 1.24 billion in 2023[1].

Key Drivers of the Lecithin Market

Several factors are driving the growth of the lecithin market:

Health and Wellness Trends

The increasing focus on health and wellness has led to a higher demand for natural and functional ingredients in food products. Lecithin, being a natural emulsifier and a source of essential nutrients, aligns well with health-conscious consumers' preferences[3].

Pharmaceutical Applications

Lecithin's role in pharmaceutical formulations, particularly as an excipient in drug delivery systems, is a significant growth driver. Its ability to enhance drug efficacy and patient adherence makes it a valuable component in the pharmaceutical sector[3].

Cosmetic and Personal Care Industry

The cosmetic and personal care industry has embraced lecithin for its natural attributes and skin-friendly properties. Its use in skincare and haircare products due to its moisturizing and hydrating properties is another key driver[1].

Animal Feed Industry

Lecithin's nutritional benefits and its ability to improve feed efficiency make it a dominant player in the animal feed industry, particularly in livestock and aquaculture[3].

Specific Applications of Dimyristoyl Lecithin

Pharmaceutical Formulations

Dimyristoyl lecithin is often used in pharmaceutical formulations due to its unique lipid molecular structure. It is particularly useful in drug delivery systems, enhancing the bioavailability and efficacy of drugs. For example, bilayer buccal tablets using dimyristoyl phosphatidylcholine have shown improved bioavailability and therapeutic efficacy compared to traditional oral tablets[2].

Cosmetic and Personal Care

In the cosmetic industry, dimyristoyl lecithin is valued for its moisturizing and hydrating properties. It is used in skincare products to maintain skin moisture and act as a soothing agent for various skin types[1].

Financial Trajectory

Market Size and Growth

The global lecithin market, which includes dimyristoyl lecithin, is expected to grow from USD 636.35 million in 2023 to USD 1076.54 million by 2030, at a CAGR of 7.8%[3].

Regional Market Dynamics

North America is projected to dominate the lecithin market during the forecast period, driven by rising demand for cosmetic products, higher disposable income, and increased focus on skincare and haircare[1].

Key Manufacturers and Market Share

Companies like Archer Daniels Midland Company, Bunge Limited, and DuPont de Nemours, Inc. are key players in the lecithin market. These companies are investing in research and development to enhance the applications and quality of lecithin products, including dimyristoyl lecithin[3].

Challenges and Opportunities

Raw Material Price Fluctuations

One of the major challenges facing the lecithin market is the fluctuation in prices of primary materials like soybeans, which can impact production costs and product prices[1].

Regulatory Compliance

The lecithin market faces diverse regulatory demands and quality criteria across different regions, posing challenges for manufacturers in ensuring compliance and maintaining market entry[1].

Emerging Markets

Emerging economies present significant opportunities for lecithin manufacturers, with growing demand for processed foods, pharmaceuticals, and cosmetics. The trend towards non-GMO and organic lecithin also offers potential for market expansion[3].

Perflexane and Related Compounds

Pharmaceutical Applications

Perflexane, a synthetic perfluorocarbon emulsion, is used in some medical applications, though it is not as widely adopted as natural lecithin. However, its use in specific medical procedures highlights the broader scope of phospholipid-based compounds in healthcare.

Key Takeaways

  • The global lecithin market is expected to grow significantly, driven by health and wellness trends, pharmaceutical applications, and demand from the cosmetic and animal feed industries.
  • Dimyristoyl lecithin plays a crucial role in pharmaceutical formulations and cosmetic products due to its unique properties.
  • The market faces challenges such as raw material price fluctuations and regulatory compliance but offers opportunities in emerging markets and the trend towards non-GMO and organic products.
  • Key manufacturers are investing in research and development to enhance the quality and applications of lecithin products.

FAQs

Q: What is the projected market size of the global lecithin market by 2032? A: The global lecithin market is expected to reach USD 2.07 billion by 2032[1].

Q: What are the primary drivers of the lecithin market? A: The primary drivers include the increasing focus on health and wellness, pharmaceutical applications, cosmetic and personal care industry demand, and the animal feed industry[3].

Q: How does dimyristoyl lecithin contribute to pharmaceutical formulations? A: Dimyristoyl lecithin enhances drug efficacy and bioavailability in pharmaceutical formulations, particularly in drug delivery systems[2].

Q: What are the challenges faced by the lecithin market? A: The market faces challenges such as raw material price fluctuations, regulatory compliance issues, and consumer preferences for synthetic emulsifiers[1].

Q: Which region is expected to dominate the lecithin market during the forecast period? A: North America is projected to dominate the lecithin market during the forecast period due to rising demand for cosmetic products and higher disposable income[1].

Sources

  1. Globenewswire: Lecithin Market Expected to Reach USD 2.07 Billion by 2032 with a CAGR of 5.86% - Introspective Market Research.
  2. Science.gov: Bilayer buccal tablets: Topics by Science.gov.
  3. Maximize Market Research: Global Lecithin Market: Global Industry Analysis and Forecast (2024-2030).

More… ↓

⤷  Subscribe

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.